Created in 2009 (United States), RILONACEPT REGN own 16 sister brands and 2214 competing brands. The RILONACEPT REGN brand is owned by Regeneron Pharmaceuticals, a company listed in New York. RILONACEPT REGN is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(RILONACEPT REGN)
over 5 years*
USD 2,276.96